ATE316977T1 - Neue pseudoerythromycin derivate - Google Patents

Neue pseudoerythromycin derivate

Info

Publication number
ATE316977T1
ATE316977T1 AT04022619T AT04022619T ATE316977T1 AT E316977 T1 ATE316977 T1 AT E316977T1 AT 04022619 T AT04022619 T AT 04022619T AT 04022619 T AT04022619 T AT 04022619T AT E316977 T1 ATE316977 T1 AT E316977T1
Authority
AT
Austria
Prior art keywords
new
derivatives
pseudoerythromycin
pseudoerythromycin derivatives
psedoerythromycin
Prior art date
Application number
AT04022619T
Other languages
English (en)
Inventor
Satoshi Omura
Yuzuru Iwai
Toshiaki Sunazuka
Tohru Nagamitsu
Original Assignee
Kitasato Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Inst filed Critical Kitasato Inst
Application granted granted Critical
Publication of ATE316977T1 publication Critical patent/ATE316977T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04022619T 2000-08-17 2000-08-17 Neue pseudoerythromycin derivate ATE316977T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2000/005503 WO2002014338A1 (en) 2000-08-17 2000-08-17 Novel pseudoerythromycin derivatives

Publications (1)

Publication Number Publication Date
ATE316977T1 true ATE316977T1 (de) 2006-02-15

Family

ID=11736361

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00953461T ATE321770T1 (de) 2000-08-17 2000-08-17 Pseudoerythromycin-derivate
AT04022619T ATE316977T1 (de) 2000-08-17 2000-08-17 Neue pseudoerythromycin derivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT00953461T ATE321770T1 (de) 2000-08-17 2000-08-17 Pseudoerythromycin-derivate

Country Status (11)

Country Link
US (1) US6734292B1 (de)
EP (2) EP1256587B1 (de)
KR (6) KR20040074096A (de)
AT (2) ATE321770T1 (de)
AU (1) AU2000265939A1 (de)
CA (1) CA2386828C (de)
DE (2) DE60027015T2 (de)
DK (1) DK1489090T3 (de)
ES (2) ES2257720T3 (de)
PT (1) PT1489090E (de)
WO (1) WO2002014338A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359244C (en) 1999-01-13 2013-10-08 Bayer Corporation .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
DK1478358T3 (da) 2002-02-11 2013-10-07 Bayer Healthcare Llc Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
WO2003068229A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
US20040067896A1 (en) * 2002-07-25 2004-04-08 The Kitasato Institute Novel pseudoerythromycin derivatives
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
PT1626714E (pt) 2003-05-20 2007-08-24 Bayer Pharmaceuticals Corp Diarilureias para doenças mediadas por pdgfr
ES2297490T3 (es) 2003-07-23 2008-05-01 Bayer Pharmaceuticals Corporation Omega-carboxiarildifenilurea fluoro sustituida para el tratamiento y prevencion de enfermadades y afecciones.
US7419962B2 (en) * 2004-12-07 2008-09-02 Enanta Pharmaceuticals, Inc. 3,6-bicyclolides
US7229972B2 (en) * 2004-12-07 2007-06-12 Enanta Pharmaceuticals, Inc. 3,6-Bicyclolides
US8278281B2 (en) 2005-08-24 2012-10-02 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
JP5118973B2 (ja) 2005-10-14 2013-01-16 学校法人北里研究所 新規ジヒドロシュードエリスロマイシン誘導体
US7407942B2 (en) * 2006-03-29 2008-08-05 Emata Pharmaceuticals, Inc 3,6-bridged 9,12-oxolides
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US20090098527A1 (en) * 2006-09-12 2009-04-16 Fischer Gerald W Biological organism identification product and methods
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8080645B2 (en) * 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
EP2772267B1 (de) 2007-08-27 2016-04-27 Longhorn Vaccines and Diagnostics, LLC Immunogene Zusammensetzungen und Verfahren
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
EP3020832A1 (de) 2007-10-01 2016-05-18 Longhorn Vaccines and Diagnostics, LLC System zum sammeln und transportieren biologischer proben sowie verfahren zur verwendung
JP5733601B2 (ja) * 2010-07-13 2015-06-10 国立大学法人 千葉大学 劇症型炎症の予防および／または治療剤
CA2863083C (en) 2012-01-26 2023-09-19 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
CA2985652C (en) 2015-05-14 2020-03-10 Gerald W. FISHER Rapid methods for the extraction of nucleic acids from biological samples

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106961A (en) 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
CA1321581C (en) * 1987-05-26 1993-08-24 Herbert A. Kirst Ring-contracted macrolides
US4920102A (en) 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders
US5554605A (en) 1991-04-09 1996-09-10 Abbott Laboratories Macrocyclic lactam prokinetic agents
KR100222014B1 (ko) 1991-04-09 1999-10-01 스티븐 에프. 웨인스톡 거대환식 락탐 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물
DE4200145A1 (de) * 1992-01-07 1993-07-08 Kali Chemie Pharma Gmbh 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE19644195A1 (de) * 1996-10-24 1998-04-30 Solvay Pharm Gmbh 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19805822B4 (de) * 1998-02-13 2009-02-05 Solvay Pharmaceuticals Gmbh 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
EP1489090B1 (de) 2006-02-01
AU2000265939A1 (en) 2002-02-25
WO2002014338A1 (en) 2002-02-21
KR20040066188A (ko) 2004-07-23
DE60025856T2 (de) 2006-10-19
EP1256587A4 (de) 2004-01-28
ES2261224T3 (es) 2006-11-16
DK1489090T3 (da) 2006-05-22
DE60025856D1 (de) 2006-04-13
KR20040074096A (ko) 2004-08-21
EP1489090A1 (de) 2004-12-22
ATE321770T1 (de) 2006-04-15
EP1256587A1 (de) 2002-11-13
CA2386828A1 (en) 2002-02-21
KR20040066185A (ko) 2004-07-23
KR20040066186A (ko) 2004-07-23
US6734292B1 (en) 2004-05-11
DE60027015D1 (en) 2006-05-18
KR20040066187A (ko) 2004-07-23
ES2257720T3 (es) 2006-08-01
PT1489090E (pt) 2006-05-31
DE60027015T2 (de) 2006-10-05
CA2386828C (en) 2006-01-24
EP1256587B1 (de) 2006-03-29
KR20040066184A (ko) 2004-07-23

Similar Documents

Publication Publication Date Title
ATE316977T1 (de) Neue pseudoerythromycin derivate
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
ECSP056195A (es) Derivados de n-alquinil-2(ariloxi-sustituido)alquiltioamida como fungicidas
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
DK1131315T3 (da) Polyhydroxylerede heterocykliske derivater som antikoagulanter
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
CY1112899T1 (el) Παραγωγα θειαδιαζολινης για τη θεραπεια του καρκινου
DK1295890T3 (da) Hidtil ukendte pyrazinderivater eller salte deraf, farmaceutiske præparater, der indeholder derivaterne eller saltene, og mellemprodukter til fremstilling af begge
ATE260275T1 (de) Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one
ATE278661T1 (de) Anthranilsäurederivate
PT992509E (pt) Novos derivados macrolidos
EA200400822A1 (ru) Производные 3,4-дигидро-1h-изохинолин-2-ила
EA200200838A1 (ru) N-(гетероциклил)бензол- или пиридинсульфонамиды в качестве антитромботических агентов и антикоагулянтов
DK1338596T3 (da) Fremgangsmåde til fremstilling af antibakterielt middel af carbapenemtypen
ATE286887T1 (de) Antibakterielle mittel
DE60105618D1 (de) Dihydroporphyrinderivate und ihre verwendung
BR0113978A (pt) Derivados de tiazol de 2-metoxiimino-2-(piridiniloximetil)-fenil-acetamidas úteis como fungicidas
BR0210749A (pt) Composições de fragrância e sabor
EA200301062A1 (ru) Фармацевтические комбинации на основе производных пиридоиндолона и противораковых агентов
BR9902348A (pt) Derivados de piridazinona
BR0110328A (pt) Compostos heterocìclicos com atividade antiinflamatória
ATE261962T1 (de) Benzonaphtyridin-1,8 derivate
DK0952157T3 (da) 9a, 11b-dehydroderivater af 9-oxim-3-keto-6-0-methylerythromycin
CY1110529T1 (el) Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1489090

Country of ref document: EP

REN Ceased due to non-payment of the annual fee